Opportunity Information: Apply for CDC RFA GH15 1544
Apply for CDC RFA GH15 1544
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Implementation of Sustainable Laboratory Quality Systems in the Republic of Kenya under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Sep 26, 2014 and posted on Aug 28, 2014.
- Applicants must submit their applications by Oct 16, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $15,000,000.00 in funding.
- The number of recipients for this funding is limited to 4 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants that can apply for this FOA are listed below Government Organizations National Ministries of Health State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) . American Indian/Alaska Native tribal governments (federally recognized or state recognized) Political subdivisions of States (in consultation with States) Non government Organizations American Indian/Alaska native tribally designated organizations Alaska Native health corporations Tribal epidemiology centers Urban Indian health organizations Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) Research institutions (that will perform activities deemed as non research) Colleges and Universities Community based organizations Faith based organizations For profit organizations (other than small business) Hospitals Small, minority, and women owned businesses All Other eligible organizations
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Implementation of Sustainable Laboratory Quality Systems in the Republic of Kenya under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" is a CDC funding announcement (Funding Opportunity Number CDC RFA GH15-1544; CFDA 93.067 Global AIDS) focused on improving Kenya's medical laboratory systems that support the diagnosis, clinical management, and public health surveillance of HIV, tuberculosis (TB), and related opportunistic infections. It is structured as a cooperative agreement, meaning the CDC is expected to have substantial involvement alongside the awardees during implementation. The overall aim is to provide hands-on technical assistance to the Government of Kenya and PEPFAR implementing partners so that laboratory services become more reliable, better coordinated, safer, and more widely accessible across the country.
The program anticipates selecting up to five grantees to cover four defined geographic regions (Regions A, B, C, and D), each spanning multiple counties. Each grantee is expected to deliver the full set of technical support activities within its assigned region. One exception is Region A, where the grantee would also provide additional support at the national level, specifically assisting the National Public Health Laboratory Services and the Ministry of Health headquarters. This design signals that the project is not only trying to improve individual laboratories, but also to strengthen national coordination, policy, and oversight functions that influence laboratory performance across the entire health system.
A major portion of the work centers on strengthening laboratory policies and operational systems end-to-end. This includes improving how specimens are handled and processed, developing and reinforcing tiered laboratory networks, and making specimen referral systems work smoothly so that patients in lower-level facilities can still access advanced testing through referral to higher-level labs. The FOA highlights priority testing areas that are critical to HIV and TB programs, including CD4 testing, HIV early infant diagnosis (EID), HIV viral load, diagnosis of opportunistic diseases, TB culture, and HIV/TB drug resistance testing. In practice, this implies helping counties and facilities build dependable referral routes, improve turnaround times, ensure correct test utilization, and reduce lost or rejected samples, all while keeping quality standards consistent across the network.
Beyond specimen and testing networks, the opportunity places strong emphasis on the "systems" that determine whether laboratory services can be sustained over time. Grantees are expected to help strengthen laboratory information management (so results are captured, transmitted, and used effectively), supplies and commodities management (so reagents and consumables are available when needed), and human capacity development (so staff are trained, supervised, and retained with the right competencies). The work also includes building stronger monitoring and evaluation practices, which typically means establishing performance indicators, routine reporting, supportive supervision, data quality checks, and using findings to guide corrective actions and continuous improvement.
Quality management systems (QMS) are a central expected deliverable. The FOA specifically calls for increased implementation of QMS using the SLIPTA approach (Strengthening Laboratory Improvements Towards Accreditation), a stepwise framework that helps laboratories progress toward internationally recognized standards. The stated outcome targets are ambitious and county-focused: establishing at least two model SLIPTA laboratories in each county and achieving ISO 15189 accreditation for at least two laboratories in each county by the end of the project period. ISO 15189 is a widely recognized international standard for medical laboratory quality and competence, so these targets indicate that the program is aiming for measurable, formal improvements rather than informal quality efforts alone.
The scope also extends into patient safety and facility-level governance for blood transfusion. Grantees must provide technical expertise to promote appropriate blood use and haemovigilance at transfusing facilities. A key mechanism named in the FOA is the establishment of hospital transfusion committees, which are meant to oversee transfusion practices, ensure adherence to guidelines, review adverse events, and promote rational blood utilization. This reflects a broader view of laboratory systems that includes not just testing but also safe clinical use of laboratory-related products and services that directly affect patient outcomes.
Biosafety and infection prevention are treated as essential components rather than add-ons. The grantees are expected to strengthen biosafety, infection control, occupational health and safety, and medical waste management. The anticipated outcomes include increasing the number of laboratories that meet minimum national biosafety and medical waste management standards. This typically involves improving infrastructure and practices such as safe specimen handling, use of personal protective equipment, staff training and incident reporting, proper segregation and disposal of infectious waste, and ensuring that facilities reduce risks to laboratory workers, patients, and surrounding communities.
In terms of what success looks like, the FOA outlines several end-of-project outcomes: expanded access to quality HIV and TB laboratory testing; broader adoption of QMS through SLIPTA with model labs and formal ISO 15189 accreditations; more laboratories meeting national biosafety and waste management standards; and more health facilities operating hospital transfusion committees and applying best practices for transfusion and haemovigilance. Taken together, these outcomes point to a program that is expected to produce tangible improvements in service coverage, quality, safety, and accountability, with progress demonstrated through recognized frameworks and standards.
Administratively, the opportunity was posted on August 28, 2014, created on September 26, 2014, and closed on October 16, 2014, with an archive date of November 15, 2014. The expected number of awards is listed as four, though the narrative notes up to five grantees, reflecting that awards could be structured based on regional coverage and the final funding decision. The award ceiling is listed as $15,000,000, there is no cost sharing or matching requirement, and the estimated total funding is shown as $0 in the extracted record, which often indicates that the total was not populated in the summary fields rather than meaning no funds were available.
Eligibility is broad and includes many organization types capable of delivering technical assistance at scale. Eligible applicants include government organizations (such as ministries of health and subnational governments), tribal governments and related entities, non-governmental organizations, community-based and faith-based organizations, colleges and universities, research institutions conducting non-research activities, hospitals, for-profit organizations (other than small businesses), and small/minority/women-owned businesses, among others. The CDC listed the Procurement and Grants Office Technical Information Management Section as a contact point for applicants who could not access the full announcement, with email and phone details provided in the notice.
Frequently Asked Questions (FAQs)
1) What is the name of this grant opportunity?
The opportunity is titled "Implementation of Sustainable Laboratory Quality Systems in the Republic of Kenya under the Presidents Emergency Plan for AIDS Relief (PEPFAR)."
2) Which agency is offering this funding opportunity?
The funding announcement is issued by the U.S. Centers for Disease Control and Prevention (CDC).
3) What is the Funding Opportunity Number (FON) and CFDA number?
Funding Opportunity Number: CDC RFA GH15-1544. CFDA: 93.067 (Global AIDS).
4) What type of award mechanism is this?
This is a cooperative agreement. That means CDC is expected to have substantial involvement with the awardees during implementation, rather than operating purely as a pass-through funder.
5) What is the overall purpose of the project?
The overall aim is to strengthen Kenya's medical laboratory systems that support diagnosis, clinical management, and public health surveillance for HIV, tuberculosis (TB), and related opportunistic infections, by providing hands-on technical assistance to the Government of Kenya and PEPFAR implementing partners.
6) What kinds of improvements does the program expect to achieve?
The program is focused on making laboratory services more reliable, better coordinated, safer, and more widely accessible across Kenya, with measurable progress tied to recognized quality and safety standards.
7) What geographic areas does the program cover?
The work is organized into four defined geographic regions (Regions A, B, C, and D), each spanning multiple counties.
8) How many awards are expected?
The announcement lists an expected number of four awards, while the narrative also notes up to five grantees. This suggests awards may be structured based on regional coverage and final funding decisions.
9) What is the expectation for coverage within a region?
Each selected grantee is expected to deliver the full set of technical support activities within its assigned region, rather than focusing on only one component of the work.
10) Is there anything unique about Region A?
Yes. The Region A grantee would also provide added support at the national level, specifically assisting the National Public Health Laboratory Services and the Ministry of Health headquarters.
11) Who are the primary beneficiaries or partners for the technical assistance?
The technical assistance is aimed at the Government of Kenya and PEPFAR implementing partners involved in laboratory services and related systems.
12) What diseases and program areas are emphasized?
The focus is on HIV and TB, including diagnosis and management of related opportunistic infections, and the laboratory services needed for clinical care and public health surveillance.
13) What laboratory testing areas are prioritized?
Priority testing areas include CD4 testing, HIV early infant diagnosis (EID), HIV viral load testing, diagnosis of opportunistic diseases, TB culture, and HIV/TB drug resistance testing.
14) What does the grant expect regarding specimen handling and referral systems?
The scope includes strengthening specimen handling and processing and improving tiered laboratory networks and specimen referral systems, so patients at lower-level facilities can access advanced testing through referral pathways to higher-level laboratories.
15) What kinds of "systems" strengthening are included beyond testing?
The FOA emphasizes strengthening laboratory information management, supplies and commodities management, and human capacity development, along with stronger monitoring and evaluation practices.
16) What is meant by laboratory information management in this program?
It refers to improving how laboratory results are captured, transmitted, and used effectively, so information can support clinical decision-making and surveillance needs.
17) What is included under supplies and commodities management?
This includes strengthening how reagents and consumables are managed so laboratories have the needed supplies available when required for consistent service delivery.
18) What does human capacity development cover?
It includes improving training, supervision, and retention so laboratory staff maintain the appropriate competencies to deliver quality services consistently.
19) What monitoring and evaluation (M&E) activities are expected?
The program anticipates strengthening performance measurement through indicators, routine reporting, supportive supervision, data quality checks, and use of findings for corrective actions and continuous improvement.
20) How central are Quality Management Systems (QMS) to this opportunity?
QMS are a central deliverable. The FOA calls for increased implementation of QMS using the SLIPTA approach as a structured pathway toward improved quality and accreditation readiness.
21) What is SLIPTA in the context of this project?
SLIPTA (Strengthening Laboratory Improvements Towards Accreditation) is described as a stepwise framework intended to help laboratories progress toward internationally recognized quality standards.
22) What accreditation standard is specifically referenced?
ISO 15189 is specifically referenced as the international standard for medical laboratory quality and competence that laboratories are expected to achieve.
23) What are the county-level targets related to SLIPTA and accreditation?
The FOA states outcome targets of establishing at least two model SLIPTA laboratories in each county and achieving ISO 15189 accreditation for at least two laboratories in each county by the end of the project period.
24) Does the scope include blood transfusion safety and governance?
Yes. The FOA includes technical expertise to promote appropriate blood use and haemovigilance at transfusing facilities.
25) What mechanism is highlighted to improve transfusion practices?
The FOA highlights establishing hospital transfusion committees to oversee transfusion practices, promote adherence to guidelines, review adverse events, and support rational blood utilization.
26) How does the program address biosafety and infection prevention?
Biosafety and infection prevention are treated as essential components, including strengthening biosafety, infection control, occupational health and safety, and medical waste management.
27) What biosafety and waste management outcomes are expected?
One stated outcome is increasing the number of laboratories that meet minimum national standards for biosafety and medical waste management.
28) What end-of-project outcomes are explicitly described?
The FOA describes outcomes including expanded access to quality HIV and TB testing; broader adoption of QMS through SLIPTA with model laboratories and ISO 15189 accreditations; more laboratories meeting national biosafety and waste management standards; and more health facilities operating hospital transfusion committees and applying best practices for transfusion and haemovigilance.
29) What is the award ceiling?
The listed award ceiling is $15,000,000.
30) Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement.
31) Why might the estimated total funding show as $0?
The extracted record shows estimated total funding as $0, which is often an indication that the total was not populated in the summary fields, rather than indicating that no funds were available.
32) When was the opportunity posted and when did it close?
It was posted on August 28, 2014, created on September 26, 2014, and closed on October 16, 2014. The archive date is November 15, 2014.
33) Who is eligible to apply?
Eligibility is broad and includes government organizations (including ministries of health and subnational governments), tribal governments and related entities, non-governmental organizations, community-based and faith-based organizations, colleges and universities, research institutions conducting non-research activities, hospitals, for-profit organizations (other than small businesses), and small/minority/women-owned businesses, among others.
34) Are for-profit entities allowed to apply?
Yes. The eligibility list includes for-profit organizations (other than small businesses) and also references small/minority/women-owned businesses among eligible applicant types.
35) What should an applicant do if they cannot access the full announcement?
The CDC listed the Procurement and Grants Office Technical Information Management Section as a contact point for applicants who could not access the full announcement, with email and phone details provided in the notice.
Browse more opportunities from the same category: Health
Next opportunity: INNOVATIVE DEVELOPMENT IN ENERGY RELATED APPLIED SCIENCE (IDEAS)
Previous opportunity: Administrative Supplements for U.S. Brazil Biomedical Collaborative Research
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 1544
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 1544) also looked into and applied for these:
| Funding Opportunity |
|---|
| Quality Data for Decision Making (QDDM) Apply for APS 386 14 000002 Funding Number: APS 386 14 000002 Agency: India USAID New Delhi Category: Health Funding Amount: $6,000,000 |
| Implementing Evidence Based Prevention Interventions for Key Populations in the Republic of Rwanda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1616 Funding Number: CDC RFA GH15 1616 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,360,627 |
| Building Institutional Capacity to Improve HIV TB Care and Treatment Service Quality in India under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1540 Funding Number: CDC RFA GH15 1540 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $750,000 |
| Expand Coverage and Improve the Quality of Facility and Community Based Prevention of Mother to Child Transmission of HIV (PMTCT) Support for Rollout of Option B Services in the Littoral and Center Regions of Cameroon under the Presidents Emergency P Apply for CDC RFA GH15 1508 Funding Number: CDC RFA GH15 1508 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $8,000,000 |
| Limited Competition Strategic Timing of Antiretroviral Treatment (START) (UM1) Apply for PAR 14 329 Funding Number: PAR 14 329 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Surveillance, Service Data Analysis and Capacity Building to Support Management, Leadership and Sustainability of HIV Programs in Haiti and other Health Initiatives under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1529 Funding Number: CDC RFA GH15 1529 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,250,000 |
| Guyana Civil Society Leadership Project Apply for RFA 538 14 000007 Funding Number: RFA 538 14 000007 Agency: Dominican Republic USAID Santo Domingo Category: Health Funding Amount: $500,000 |
| Affordable Care Act Maternal, Infant and Early Childhood Home Visiting Formula Grant Program Apply for HRSA 15 101 Funding Number: HRSA 15 101 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Affordable Care Act Maternal, Infant and Early Childhood Home Visiting Program Grants Apply for HRSA 15 102 Funding Number: HRSA 15 102 Agency: Health Resources and Services Administration Category: Health Funding Amount: $9,400,000 |
| NIMH Career Transition Award for Tenure Track and Tenured Intramural Investigators (K22) Apply for PAR 14 330 Funding Number: PAR 14 330 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening of the Human Resources Information System and Development of Open Health Information Enterprise Architecture in the Republic of Zimbabwe under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1604 Funding Number: CDC RFA GH15 1604 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $600,000 |
| Enhancing Strategic Information Capacity for HIV/AIDS Programs in Kenya through Surveillance and Epidemiology, Monitoring and Evaluation and Mobile Health Solutions under the U.S. Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1543 Funding Number: CDC RFA GH15 1543 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $9,800,000 |
| Comprehensive High Impact HIV Prevention Projects for Community Based Organizations Apply for CDC RFA PS15 1502 Funding Number: CDC RFA PS15 1502 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $450,000 |
| Strengthening Laboratory and Blood Transfusion Services in South Sudan under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1571 Funding Number: CDC RFA GH15 1571 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,200,000 |
| Information System Development and Systems Integration Support for National HIV and Health Sector Systems in the Republic of Tanzania under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1586 Funding Number: CDC RFA GH15 1586 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $900,000 |
| Partnership for State Title V Maternal and Child Health Leadership Community Cooperative Agreement Apply for HRSA 15 071 Funding Number: HRSA 15 071 Agency: Health Resources and Services Administration Category: Health Funding Amount: $1,537,500 |
| Planning Grants for Dental, Oral and Craniofacial Tissue Regeneration Consortium Resource Centers (R34) Apply for RFA DE 15 005 Funding Number: RFA DE 15 005 Agency: National Institutes of Health Category: Health Funding Amount: $125,000 |
| National State Based Tobacco Control Programs Apply for CDC RFA DP15 1509 Funding Number: CDC RFA DP15 1509 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $23,000,000 |
| TECHNICAL ASSISTANCE TO OBTAIN STATE AND TERRITORIAL HEALTH DEPARTMENT INPUT FOR NATIONAL HEALTH SECURITY RELATED ACTIVITIES Apply for EP HIT 14 004 Funding Number: EP HIT 14 004 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $60,000 |
| National Maternal and Child Health Data Resource Center Cooperative Agreement Program Apply for HRSA 15 108 Funding Number: HRSA 15 108 Agency: Health Resources and Services Administration Category: Health Funding Amount: $750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 1544", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.